Latest news on Cell and gene therapy CRO market Research Report by 2035

Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.
 A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.
 Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.
 A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.
 An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.
 A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.
 A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.
 A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Area of Expertise
 Cell Therapy
 Gene Therapy

 Scale of Operation
 Preclinical
 Clinical
 Drug Discovery

 Therapeutic Area
 Oncological Disorders
 Neurological Disorders
 Cardiovascular Disorders
 Infectious Diseases
 Metabolic Disorders
 Autoimmune Disorders
 Blood Disorders
 Rare / Genetic Disorders
 Ophthalmic Disorders
 Other disorders

 Analysis by Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa

Key companies covered in the report
 Altasciences
 Charles River Laboratories
 Creative Biolabs
 IQVIA
 Medpace
 PPD
 Precision for Medicine
 Accelera
 Evotec
 ICON
 Syneos Health
 CMIC Group
 Labcorp

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

News article
AI-based digital pathology market

Learn from experts: do you know about these emerging industry trends?
TCR Therapies: An Emerging Therapeutic Modality
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#atmps #genetherapycro #cellandgenetherapycompanies #marketresearch #marketinsights

Lab Automation market Size, Share, Trends by 2035

The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks.

As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory.

The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:
 Stage of Automation
 Pre-Analytical
 Analytical
 Post-Analytical
 Total Lab Automation

 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments

 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Abbott
 Anton Paar
 BD
 Beckman Coulter
 ERWEKA
 Leuze
 Ortho Clinical Diagnostics
 Pall Corporation
 PerkinElmer
 Roche Diagnostics
 Siemens Healthineers
 SYSTAG

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Partnerships and Collaborations

8. Patent Analysis

9. Market Forecast and Opportunity Analysis

10. Case Study: Lab Automation Software

11. Executive Insights

12. Appendix 1: Tabulated Data

13. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/lab-automati

News article
Biopharmaceutical Filtration Market

Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
T-cell Immunotherapies: The Future of Modern Cancer Treatments

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#labautomation #laboratoryautomation #laboratoryautomationmarket #marketresearch #marketinsights

Conjugation and Labeling Services market Share, Growth Analysis by 2035

The growing interest of various stakeholders in conjugated and labeled molecules for therapeutic and diagnostic applications had led to a surge in demand for these complex molecules.

The conjugates / labels incorporated in the molecules are known to offer target specificity, bioavailability, improved pharmacokinetic property and membrane permeability. Moreover, these bioconjugates support the robust and sensitive detection of the target molecule of interest. The construction of homogenous bioconjugates require multidisciplinary expertise and advanced bioconjugation technologies that can be accessed through service providers.

The financial opportunity within the conjugation and labeling services market has been analyzed across the following segments:
 Type of Molecule
 Proteins
 Peptides
 Small Molecules
 Antibodies
 Other Molecules

 Type of Molecular Conjugate / Label
 Polymers
 Haptens
 Enzymes
 Fluorescent Tags
 Bead Coupling / Particle Conjugates
 Quantum Dots
 Isotopes
 Other Molecular Conjugates / Labels

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The Conjugation and Labeling Services Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 AltaBioscience
 Bachem
 Bio-Synthesis
 Cayman Chemical
 CliniSciences
 Eurogentec
 GBI
 Mimotopes
 Peptide Institute
 piCHEM

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Conjugation and Labeling Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Partnerships and Collaborations

8. Global Event Analysis

9. SWOT Analysis

10. Market Forecast and Opportunity Analysis

11. Conclusion

12. Interview Transcripts

13. Appendix 1: Tabulated Data

14. Appendix 2: List of Companies and Organizations

For additional details, please visit https://www.rootsanalysis.com/....reports/conjugation-

News article
CAR-T cell therapy market

Learn from experts: do you know about these emerging industry trends?
Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential
Rising Demand for Medical Devices CROs

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#bioconjugation #antibodylabeling #proteinlabeling #marketresearch #marketinsights

Analysis of Patient Recruitment Services and Patient Retention Services market Strategies and Forecasts to 2035

Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expediate the drug development timelines

Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”

The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:
 A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.
 A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials.
 A detailed assessment of the overall landscape of patient recruitment companies and patient retention companies offering these services.
 A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large).
 Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific.
 An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022.
 A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence.
 A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.
 A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework.
 A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases.
 A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
 A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Patient Recruitment Step
 Pre-screening
 Screening

 Trial Phase
 Phase I
 Phase II
 Phase III
 Phase IV

 Therapeutic Area
 Cardiovascular Disorders
 Oncological Disorders
 Infectious Diseases
 CNS Disorders
 Respiratory Disorders
 Hematological Disorders
 Dermatological Disorders
 Ophthalmic Disorders
 Others

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

Transcripts of interviews held with the following senior level representatives of stakeholder companies:
 Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
 Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
 Simon Klaasen (Co-founder and Managing Director, Link2Trials)
 Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
 Ken Shore (Chief Commercial Officer, Continuum Clinical)
 Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
 Paul Ivsin (Ex-Managing Director, Seeker Health)
 Kasturi Lakhe (Inside Sales Specialist, EVERSANA)

Key companies covered in the report
 BBK Worldwide
 Continuum Clinical
 IQVIA
 United BioSource (UBC)
 WCG ThreeWire
 Clariness
 Fidelis Research
 Ignite Data
 Innovative Trials
 Orphan Reach
 3H Medi Solution
 Buzzreach
 Current Medical Information Center (CMIC)
 nRollmed
 Trialfacts

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

News article
Global Cell Free Expression Market

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

4D Bioprinting Market: Key Trends

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com

#patientrecruitmentcompanies #clinicaltrialrecruitmentcompanies #patientrecruitmentservices #marketresearch #marketinsights

Digital twin market 2023 – Industry Growth by 2035

Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain

The USD 29.8 billion (by 2035) financial opportunity within digital twin market has been analyzed across the following segments:
 Therapeutic Area
 Cardiovascular Disorders
 Metabolic Disorders
 Orthopedic Disorders
 Other Disorders

 Type of Digital Twin
 Process Twins
 System Twins
 Whole Body Twins
 Body Part Twins

 Area of Application
 Asset / Process Management
 Personalized Treatment
 Surgical Planning
 Diagnosis
 Other Applications

 End Users
 Pharmaceutical Companies
 Medical Device Manufacturers
 Healthcare Providers
 Patients
 Other End Users

 Key Geographical Regions
 North America
 Europe
 Asia
 Latin America
 Middle East and North Africa
 Rest of the World

The Digital Twins Market, 2022-2035, report features the following companies, which we identified to be key players in this domain:
 Babylon
 ExactCure
 ImmersiveTouch
 Navv Systems
 ThoughtWire
 Unlearn.AI

The latest report also provides key insights for Digital Twin Technology and Digital Twins Providers

Table of Contents
1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Key Insights

6. Company Competitiveness Analysis

7. Company Profiles

8. Partnerships and Collaborations

9. Funding and Investments Analysis

10. Berkus Start-up Valuation Analysis

11. Market Forecast

12. Conclusion

13. Executive insights

14. Appendix I: Tabulated data

15. Appendix II: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/digital-twin

You may also be interested in the following titles:
Buffer Preparation Market
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Quantum Computing in Drug Discovery Services Market
Roots Analysis Consulting - the preferred research partner for global firms

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#digitaltwins #digitaltwin #digitaltwintechnology #marketresearch #marketinsights